EPO squeezes hESC patenting in line with EU court ruling, but impact could be limited
This article was originally published in SRA
Executive Summary
The European Patent Office has declared that a stem cell invention derived using a method that necessarily involves the destruction of a human embryo cannot be patented1,2. In doing so, it has followed last year's ruling from the Court of Justice of the EU, even though as a non-EU body it was not bound to do so.